Background/Aims The epidemiology of Chagas disease, until recently confined to areas of continental Latin America, has undergone considerable changes in recent decades due to migration to other parts of the world, including Spain. We studied the prevalence of Chagas disease in Latin American patients treated at a health center in Barcelona and evaluated its clinical phase. We make some recommendations for screening for the disease. Methodology/Principal Findings We performed an observational, cross-sectional prevalence study by means of an immunochromatographic test screening of all continental Latin American patients over the age of 14 years visiting the health centre from October 2007 to October 2009. The diagnosis was confirmed by serological methods: conventional in-house ELISA (cELISA), a commercial kit (rELISA) and ELISA using T cruzi lysate (Ortho-Clinical Diagnostics) (oELISA). Of 766 patients studied, 22 were diagnosed with T. cruzi infection, showing a prevalence of 2.87% (95% CI, 1.6–4.12%). Of the infected patients, 45.45% men and 54.55% women, 21 were from Bolivia, showing a prevalence in the Bolivian subgroup (n = 127) of 16.53% (95% CI, 9.6–23.39%). All the infected patients were in a chronic phase of Chagas disease: 81% with the indeterminate form, 9.5% with the cardiac form and 9.5% with the cardiodigestive form. All patients infected with T. cruzi had heard of Chagas disease in their country of origin, 82% knew someone affected, and 77% had a significant history of living in adobe houses in rural areas. Conclusions We found a high prevalence of T. cruzi infection in immigrants from Bolivia. Detection of T. cruzi–infected persons by screening programs in non-endemic countries would control non-vectorial transmission and would benefit the persons affected, public health and national health systems.
References
[1]
Brice?o-Leon R (2009) Chagas disease in the Americas: an ecohealth perspective. Cad Saúde Pública, Rio de Janeiro 25: S71–S82.
[2]
Pan American Health OrganizationPrograma Regional de Chagas de la OPS. Available: http://www.paho.org/spanish/ad/dpc/cd/dc?h-program-page.htm Accessed 28 April 2011.
[3]
Jackson Y, Angheben A, Carrilero Fernandez B, Jansà i López del Vallado JM, Jannin JG, et al. (2009) Prise en charge de la maladie de Chagas en Europe. Expériences et défis en Espagne, Suisse et Italie. Bull Soc Pathol Exot 102: 326–329.
[4]
Gascón J, Pinazo MJ (2008) Control de la transmisión vertical de Trypanosoma cruzi en Espa?a: principal reto de la patología importada. Enferm Infecc Microbiol Clin 26: 605–6. doi: 10.1016/S0213-005X(08)75274-1
[5]
Instituto Nacional de Estadística, Espa?a. Available: http://www.ine.es. Accessed 2010 May 26.
[6]
Gascón J, Bern C, Pinazo MJ (2010) Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 115: 22–27. doi: 10.1016/j.actatropica.2009.07.019
[7]
Develoux M, Lescure FX, Jaureguiberry S, Jeannel D, Elghouzzi MH, et al. (2010) Emergence of Chagas' disease in Europe: description of the first cases observed in Latin American immigrants in mainland France. Med Trop (Mars) 70: 38–42.
[8]
Guerri-Guttenberg RA, Ciannameo A, Di Girolamo C, Milei JJ (2009) Chagas disease: an emerging public health problem in Italy?. Infez Med 17: 5–13.
[9]
Mu?oz J, Gómez i Prat J, Gállego M, Gimeno F, Trevi?o B, et al. (2009) Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop 111: 51–5. doi: 10.1016/j.actatropica.2009.02.005
[10]
Mu?oz J, Coll O, Juncosa T, Vergés M, del Pino M, et al. (2009) Prevalence and vertical transmission of Trypanosoma cruzi infections among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis 8: 1736–40.
[11]
Lucas RM, Barba MC (2009) Prevalence of American trypanosomiasis in pregnant women from a health area of Valencia, Spain: 2005–2007. Rev Esp Salud Publica 83: 543–55.
[12]
Jackson Y, Gétaz L, Wolff H, Holst M, Mauris A, et al. (2010) Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis 4: e592. doi: 10.1371/journal.pntd.0000592
[13]
Pirón M, Vergés M, Mu?oz J, Casamitjana N, Sanz S, et al. (2008) Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 48: 1862–8. doi: 10.1111/j.1537-2995.2008.01789.x
[14]
Kun H, Moore A, Mascola L, Steurer F, Lawrence G, et al. (2009) Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 48: 1534–40. doi: 10.1086/598931
[15]
Nowicki MJ, Chinchilla C, Corado L, Matsuoka L, Selby R, et al. (2006) Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk. Transplantation 81: 477–479. doi: 10.1097/01.tp.0000195778.08411.b8
[16]
Soriano Arandes A, Mu?oz Gutierrez J, Vergés Navarro M, Castells Doménech C, Portus Vinyeta M, et al. (2009) Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain). Acta Trop 112: 228–230. doi: 10.1016/j.actatropica.2009.07.014
[17]
Walley J, Lawn JE, Tinker A, de Francisco A, Chopra M, et al. (2008) Primary health care: making Alma-Ata a reality. Lancet 372: 1001–7. doi: 10.1016/S0140-6736(08)61409-9
[18]
Gascón J, en representación del Grupo de Trabajo del Taller “Enfermedad de Chagas importada: ?un Nuevo reto de Salud Pública? (2005) Diagnóstico y tratamiento de la Enfermedad de Chagas importada. Med Clin (Barc.) 125: 230–5. doi: 10.1157/13077386
[19]
Gascón J, Albar P, Ca?as E, Flores M, Gómez i Prat J, et al. (2007) Diagnóstico, manejo y tratamiento de la cardiopatía chagásica crónica en áreas donde la infección por Trypanosoma cruzi no es endémica. Rev Esp Cardiol 60: 285–93. doi: 10.1016/S1885-5857(07)60153-4
[20]
Rassi A, Rassi A, Marín-Neto JA (2010) Chagas disease. Lancet 375: 1388–1402. doi: 10.1016/S0140-6736(10)60061-X
[21]
Census of the Barcelona City Council Available: http://www.bcn.es/estadistica/catala/dad?es/index.htm. Accessed 2010 Mar 30.
[22]
Programa de Actividades Preventivas y de Promoción de la Salud Available: http://www.papps.org/. Accessed 2010 May 31.
[23]
Riera C, Vergés M, López-Chejade P, Pirón M, Gascón J, et al. (2009) Desarrollo y evaluación de una técnica ELISA con antígeno crudo de Trypanosoma cruzi para el diagnóstico de la efermedad de Chagas. Enf Emerg 11: 22–9.
[24]
WHO (2002) Control of Chagas disease. 2nd report of the World Health Organization Expert Committee. WHO Technical Report Series 905: 1–101.
[25]
López-Chejade P, Roca C, Posada E, Pinazo MJ, Gascón J, et al. (2010) Utilidad de un test inmunocromatográfico para el cribado de la enfermedad de Chagas en asistencia primaria. Enferm Infecc Microbiol Clín 28: 169–71.
[26]
Pinazo MJ, Ca?as E, Elizalde JI, García M, Gascón J, et al. (2010) Diagnosis, management and treatment of chronic Chagas' gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic. Gastroenterol Hepatol 33: 191–200. doi: 10.1016/j.gastrohep.2009.07.009
[27]
Bern C, Montgomery SP, Herwaldt BL, Rassi A, Marin-Neto JA, et al. (2007) Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review. JAMA 298: 2171–2181. doi: 10.1001/jama.298.18.2171
[28]
Padrón municipal de habitantes. Institut Municipal d'Estadística. Ayuntamiento de Barcelona (2005) ABS 10G El Clot: equivalencia exacta con las zonas estadísticas de búsqueda 234 y 240 del Ayuntamiento de Barcelona.
[29]
Steele LS, MacPherson DW, Kim J, Keystone JS, Gushulak BD (2007) The sero-prevalence of antibodies to Trypanosoma cruzi in Latin American refugees and immigrants to Canada. J Immigr Minor Health 9: 43–7. doi: 10.1007/s10903-006-9014-x
[30]
Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, et al. (2008) Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood. J Clin Microbiol 46: 2022–7. doi: 10.1128/JCM.02303-07
[31]
Flores-Chávez M, Cruz I, Rodríguez M, Nieto J, Franco E, et al. (2010) Comparación de técnicas serológicas convencionales y no convencionales para el diagnóstico de la enfermedad de Chagas importada en Espa?a. Enferm Infecc Microbiol Clin 28: 284–293. doi: 10.1016/j.eimc.2009.07.005
[32]
Lescure FX, Canestri A, Melliez H, Jauréguiberry S, Develoux M, et al. (2008) Chagas disease, France. Emerg Infect Dis 14: 644–646. doi: 10.3201/eid1404.070489
[33]
Bern C, Montgomery SP (2009) An estimate of the Burden of Chagas Disease in the United States. Clin Infect Dis 49: e52–e54. doi: 10.1086/605091
[34]
El Ghouzzi MH, Boiret E, Wind F, Brochard C, Fittere S, et al. (2010) Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening. Transfusion 50: 575–83. doi: 10.1111/j.1537-2995.2009.02476.x
[35]
Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL (2008) Chagas disease and the US blood supply. Curr Opin Infect Dis 21: 476–82. doi: 10.1097/QCO.0b013e32830ef5b6
[36]
Ministerio de Sanidad y Consumo. Espa?a. Real Decreto sobre hemodonación (Real Decreto 1088/2005). Boletín Oficial del Estado. Available: http://www.boe.es/boe/dias/2005/09/20/pd?fs/A31288-31304.pdf. Accessed 2010 Sept 01.
[37]
Departament de Salut, Generalitat de Catalunya. Protocol de cribatge i diagnòstic de malaltia de Chagas en dones embarassades llatinoamericanes i en els seus nadons. Available: http://www.gencat.cat/salut/depsalut/htm?l/ca/dir2384/protchagas2010.pdf. Accessed 2010 Sept 01.
[38]
Conselleria de Salut, Comunitat Valenciana. Enfermedad de Chagas importada. Protocolo de actuación en la Comunitat Valenciana. Available: http://www.matronas-cv.org/categorias-pr?incipales/documentos/profesionales/i/475?/65/enfermedad-de-chagas-importada-proto?colo-de-actuacion-en-la-comunitat-valenc?iana Accessed 2010 Sept 01.
[39]
Viotti R, Vigliano C, Armenti A (2009) Nothing Goes on Forever… Chagas Disease. Rev Esp Cardiol 62: 1332–44. doi: 10.1016/S0300-8932(09)73087-8
[40]
Maguire JH (2006) Chagas' Disease – Can we stop the deaths? N Engl J Med 355: 760–761. doi: 10.1056/NEJMp068130
[41]
WHO 2010.Chagas disease: control and elimination. Report by the Secretariat. Available: http://apps.who.int/gb/ebwha/pdf_files/W?HA63/A63_17-en.pdf. Accessed 2010 Sept 02.
[42]
Ponce C (2007) Current situation of Chagas disease in Central America. Mem Inst Oswaldo Cruz 102: 41–44. doi: 10.1590/S0074-02762007005000082